|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Loss for the year | |||||
| Items not affecting operating activities: | |||||
| Interest income | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Items not affecting cash: | |||||
| Gain (loss) on revaluation of investments | |||||
| Equity income from investment in SLM California (Note 6) | |||||
| Share-based payments (Note 16) | |||||
| Bonus shares issued | |||||
| Gain on debt and receivable modification | |||||
| Loss (gain) on debt modification and provisioning of receivables (Note 5 and 10 ) | |||||
| Loss (gain) on revaluation and provisioning of receivables (Note 5) | |||||
| Deferred income tax expense (recovery) (Note 11) | |||||
| Depletion and depreciation (Note 7) | |||||
| Depletion | |||||
| Finance charges, net of settlement gains | |||||
| Realized (gain) loss on sale of investments | |||||
| Finance expense (Note 10) | |||||
| Impairment charges (Note 7) | |||||
| Shares received pursuant to property agreements | |||||
| Unrealized foreign exchange (gain) loss | |||||
| Other non-cash movements (Note 21) | |||||
| Changes in non-cash working capital items (Note 21) | |||||
| Total cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Option payments received | |||||
| Interest received on cash and cash equivalents | |||||
| Dividends and other distributions (Note 6) | |||||
| Loan receivable (Note 17) | |||||
| Proceeds from loan repayment (Note 17) | |||||
| Acquisition of royalty and other property interests, net | |||||
| Acquisition of royalty and other property interests, net (Note 7) | |||||
| Purchase of investment in SLM California (Note 6) | |||||
| Proceeds from the sale of preferred shares in Ensero Holdings Inc. (Note 4) | |||||
| Sale of fair value through profit and loss investments, net | |||||
| Sale (purchases) of fair value through profit and loss investments, net | |||||
| Loans receivable | |||||
| Purchase and sale of property and equipment, net | |||||
| Reclamation bonds | |||||
| Other movements (Note 21) | |||||
| Total cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Loans payable | |||||
| Proceeds from Franco-Nevada loan (Note 10) | |||||
| Loan repayments (Note 10) | |||||
| Proceeds from private placement | |||||
| Share issue costs | |||||
| Interest paid (Note 10) | |||||
| Purchase of common shares returned to treasury | |||||
| Proceeds from exercise of options and settlement of RSUs, net | |||||
| Deferred financing costs | |||||
| Financing costs | |||||
| Total cash used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Change in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning | |||||
| Cash and cash equivalents, ending | |||||
Loading...